ArticlePLOS global public health2024
Costing the intergovernmental negotiating body (INB) process.
Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diplomatic roles of regional coordinators for WHO Member States.Bulletin of the World Health Organization · 2026Article
- Defining collaborative surveillance to improve decision making for public health emergencies and beyond.Lancet (London, England) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Intergovernmental Negotiating Body (INB) was established to draft and negotiate a pandemic instrument to strengthen pandemic preparedness and response (PPR). This has been carried out under the auspices of the World Health Organization (WHO), and has to date involved 15 sessions in Geneva, plus countless hours both in informal working groups, and in capitals working on government positions on each substantive issue. This all comes at a cost, both in terms of human resource and travel costs associated with the development of an international treaty and its associated process. We begin to quantify the cost of this process as approximately US$ 201,343,032. If we also consider estimated costs for the parallel WGIHR process to be US$56,024,830, we estimate the total cost of this combined governance development to be US$257,367,862. We position this in the context of how much pandemic preparedness is thought to cost on an annual basis, and the opportunity costs of investing in this governance process instead of more operational areas of health security. Moreover, in doing so, we offer one of the first financial estimates of the cost of developing and negotiating multilateral treaties.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.